|
WASHINGTON, DC - MetLife Foundation's Award for Medical Research in Alzheimer's Disease was presented in Washington, DC today to Bruce A. Yankner, MD, PhD, of Harvard Medical School and Children's Hospital Boston, in recognition of his efforts and contributions to understanding Alzheimer's disease (AD).
Dr. Yankner received a grant of $200,000 to further his work in AD research, as well as a $50,000 personal award. Also recognized were Lennart Mucke, MD of the Gladstone Institute of Neurological Disease, San Francisco and David Holtzman, MD of Washington University School of Medicine in St. Louis for the strides each has made in their AD research. Each received a $100,000 grant to their respective institutions in support of their continued research.
The MetLife Foundation Award for Medical Research recognizes scientists whose work has significantly contributed to understanding AD. The program's unrestricted grants enable scientists to liberally pursue their creative ideas as they relate to AD research. A total of $8.5 million has been awarded since the inception of the program in 1986.
Commented Robert H. Benmosche, Chairman and CEO of MetLife, "Alzheimer's is a tragic disease affecting millions of Americans, their families and friends. MetLife is proud to support the research that is occurring across the country to find a solution to Alzheimer's. It is amazing to see the continued strides that have been made by researchers as they come closer to understanding this disease."
|